日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Reactivation of PPAR α alleviates myocardial lipid accumulation and cardiac dysfunction by improving fatty acid β-oxidation in Dsg2-deficient arrhythmogenic cardiomyopathy

PPAR α 的重新激活可通过改善 Dsg2 缺陷型心律失常性心肌病中的脂肪酸 β-氧化来减轻心肌脂质积聚和心脏功能障碍

Yubi Lin, Ruonan Liu, Yanling Huang, Zhe Yang, Jianzhong Xian, Jingmin Huang, Zirui Qiu, Xiufang Lin, Mengzhen Zhang, Hui Chen, Huadong Wang, Jiana Huang, Geyang Xu

SGLT2 inhibitor dapagliflozin attenuates cardiac fibrosis and inflammation by reverting the HIF-2α signaling pathway in arrhythmogenic cardiomyopathy

SGLT2 抑制剂达格列净通过逆转心律失常性心肌病中的 HIF-2α 信号通路来减轻心脏纤维化和炎症

Zhe Yang, Tengling Li, Jianzhong Xian, Jia Chen, Yin Huang, Qin Zhang, Xiufang Lin, Hongyun Lu, Yubi Lin

Interleukin-27 decreases ghrelin production through signal transducer and activator of transcription 3-mechanistic target of rapamycin signaling

白细胞介素-27 通过信号转导和转录激活因子 3-雷帕霉素信号传导机制靶点降低生长素释放肽的产生

Heng Zhang, Qingjie Li, Yuxin Teng, Yubi Lin, Shaojian Li, Tingfeng Qin, Linxi Chen, Jiana Huang, Hening Zhai, Quan Yu, Geyang Xu